TY - JOUR
T1 - Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization
AU - Chiu, John H.
AU - Topol, Eric J.
AU - Whitlow, Patrick L.
AU - Hsu, Amy P.
AU - Tuzcu, E. Murat
AU - Franco, Irving
AU - Moliterno, David J.
N1 - Funding Information:
TARGET was supported by Merck and Co., Inc., West Point, Pennsylvania.
PY - 2003/8/22
Y1 - 2003/8/22
N2 - The association between peripheral vascular disease and outcomes after percutaneous coronary intervention was examined in the Do Tirofiban and Reopro Give Similar Efficacy Outcome Trial (TARGET). After adjustments in a multivariate model, a history of peripheral vascular disease was found to be associated with a two- to threefold increase in mortality at 1 year after coronary stent placement.
AB - The association between peripheral vascular disease and outcomes after percutaneous coronary intervention was examined in the Do Tirofiban and Reopro Give Similar Efficacy Outcome Trial (TARGET). After adjustments in a multivariate model, a history of peripheral vascular disease was found to be associated with a two- to threefold increase in mortality at 1 year after coronary stent placement.
UR - http://www.scopus.com/inward/record.url?scp=0043011389&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0043011389&partnerID=8YFLogxK
U2 - 10.1016/S0002-9149(03)00726-4
DO - 10.1016/S0002-9149(03)00726-4
M3 - Article
C2 - 12943879
AN - SCOPUS:0043011389
SN - 0002-9149
VL - 92
SP - 582
EP - 583
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 5
ER -